SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 74.21 |
Enterprise Value ($M) | 74.22 |
Book Value ($M) | 28.34 |
Book Value / Share | 1.89 |
Price / Book | 2.62 |
NCAV ($M) | -9.72 |
NCAV / Share | -0.65 |
Price / NCAV | -7.64 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.07 |
Return on Assets (ROA) | -0.04 |
Return on Equity (ROE) | -0.12 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.09 |
Current Ratio | 1.25 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 31.88 |
Assets | 69.94 |
Liabilities | 41.60 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 37.87 |
Operating Income | -6.43 |
Net Income | -6.48 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -0.61 |
Cash from Investing | 0.06 |
Cash from Financing | 0.20 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Ikarian Capital, LLC | 4.90 | ||
13G/A | Integrated Core Strategies (us) Llc | 5.80 | -34.14 | |
13G | Kazimi A J | 40.80 | -0.89 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
1,729 | 21,004 | 8.23 | |
11,469 | 85,588 | 13.40 | |
16,334 | 70,362 | 23.21 | |
2,851 | 35,849 | 7.95 | |
(click for more detail) |
Similar Companies | |
---|---|
CGON – CG Oncology, Inc. | COGT – Cogent Biosciences, Inc. |
COLL – Collegium Pharmaceutical, Inc. | CRBU – Caribou Biosciences, Inc. |
CRGX – CARGO Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io